A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Researchers at Columbia’s Center for Infection and Immunity (CII) have discovered an uncommon bacterium, Sutterella, in the intestines of 12 of 23 children who had both autism and GI problems.
Researchers at Columbia University Medical Center (CUMC) have identified a molecular pathway that controls the retention and release of the brain’s stem cells.